Bill Text: NY A01017 | 2025-2026 | General Assembly | Introduced

---

Bill Title: Provides for education and outreach for drug-induced movement disorders by the department of health through the health care and wellness education and outreach program.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Engrossed) 2025-01-22 - REFERRED TO RULES [A01017 Detail]

Download: New_York-2025-A01017-Introduced.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                          1017

                               2025-2026 Regular Sessions

                   IN ASSEMBLY

                                       (Prefiled)

                                     January 8, 2025
                                       ___________

        Introduced by M. of A. PAULIN -- read once and referred to the Committee
          on Health

        AN  ACT  to  amend the public health law, in relation to authorizing the
          health care and wellness education and outreach program to develop and
          disseminate information regarding drug-induced movement disorders

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section 1. Paragraph (h) of subdivision 1 of section 207 of the public
     2  health  law,  as  added  by  a  chapter of the laws of 2024 amending the
     3  public health law  relating  to  establishing  a  drug-induced  movement
     4  disorder  screening  education program, as proposed in legislative bills
     5  numbers S. 8965-A and A. 6799-B, is amended to read as follows:
     6    (h) [The department shall develop and  conduct  a  program  concerning
     7  drug-induced]  Drug-induced  movement  disorders[.  Such  program  shall
     8  include but not be limited to, (i) educational information on],  includ-
     9  ing the importance of screening for and identifying symptoms of drug-in-
    10  duced movement disorders[; and (ii) the development and dissemination of
    11  educational materials for healthcare providers regarding], treatment for
    12  drug-induced  movement  disorders,  [including for services provided via
    13  telehealth.  Such] and information on methods by which the stigma  expe-
    14  rienced by people living with drug-induced movement disorders related to
    15  the  treatment of mental health conditions may be reduced or eliminated.
    16  Any such educational  materials  disseminated  to  healthcare  providers
    17  shall  be  developed  [and] in consultation with the commissioner of the
    18  office of mental health, disseminated by the department in  coordination
    19  with  relevant  healthcare provider groups, and shall include best prac-
    20  tices for the treatment and screening of movement disorders informed  by
    21  the  American  Psychiatric  Association  and  other professional society
    22  practice guidelines.   [Such program shall also  include  education  and
    23  outreach  on  the  elimination of stigma for people living with drug-in-

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02693-01-5
        A. 1017                             2

     1  duced movement disorders related  to  the  treatment  of  mental  health
     2  conditions.]
     3    §  2.  This  act  shall  take  effect on the same date and in the same
     4  manner as a chapter of the laws of 2024 amending the public  health  law
     5  relating  to  establishing  a  drug-induced  movement disorder screening
     6  education program, as proposed in legislative bills  numbers  S.  8965-A
     7  and A. 6799-B, takes effect.